Abstract: In examples described herein, methods for via pillar placement and an integrated circuit design including a via pillar are described. In some instances, a path within an integrated circuit or proposed integrated circuit design can be identified as having negative slack. In such instances, in particular where the path includes a fanout to input pins of receivers, a via pillar can be inserted at a location prior to fanout of the path. The via pillar can be inserted, for example, proximate to the fanout, but between the fanout and an output pin of a driver that is connected to the path.

Abstract: A fan assembly, configured to be mounted on a casing, includes a fan, two mounting frames, and two fixing elements. The mounting frames are disposed on two opposite sides of the fan, and the mounting frames are detachably disposed on the casing via the fixing elements. The structures and the sizes of the mounting frames are the same.

Abstract: The present invention generally relates to a genetically modified fungal cell capable of producing a very long, chain fatty acid (VLCFA) and/or a VLCFA derivative. The genetically modified fungal cell comprises at least one exogenous gene encoding a fatty acyl-CoA reductase, and at least one gene encoding an elongase, and/or at least one gene encoding a fatty acid synthase.

Abstract: The present invention relates to Fused Tricyclic Heterocyclic Compounds of Formula (I): and pharmaceutically acceptable salts thereof, wherein R1, R2 and R3 are as defined herein. The present invention also relates to compositions comprising at least one Fused Tricyclic Heterocyclic Compound, and methods of using the Fused Tricyclic Heterocyclic Compounds for treating or preventing HIV infection in a subject.

Abstract: Aspects of the embodiments are directed to methods and imaging systems. The imaging systems can be configured to sense, by an light sensor of the imaging system, light received during a time period, process the light received by the light sensor, identify an available measurement period for the imaging system within the time period based on the processed light, and transmit and receive light during a corresponding measurement period in one or more subsequent time periods.

Abstract: Aspects of the embodiments are directed to methods and imaging systems. The imaging systems can be configured to sense, by an light sensor of the imaging system, light received during a time period, process the light received by the light sensor, identify an available measurement period for the imaging system within the time period based on the processed light, and transmit and receive light during a corresponding measurement period in one or more subsequent time periods.

Abstract: The invention provides a light field illuminating method, device and system. The method includes: determining, based on position and angle of rays emitted from a projector and focal length of a lens, position and angle of projection rays obtained after the emitted rays being transmitted through a lens array; determining, based on position and angle of projection rays and light probe array of sampled scene, brightness value of projection rays; converting, based on brightness transfer function of projector, brightness value of projection rays into pixel value of projection input image, generating projection input image based on pixel value of projected input image; and performing light field illumination on target object with projection input image. A projector and a lens array are adopted to achieve light field illumination, so that pixel-level accurate lighting control can be achieved, and various complicated light field environments can be simulated vividly in practical scenario.

Abstract: The present invention relates to Phosphate Substituted Quinolizine Derivatives of Formula (I): and pharmaceutically acceptable salts or prodrug thereof, wherein X, Y, R1, R2, R3, R4, R5, R9 and R10 are as defined herein. The present invention also relates to compositions comprising at least one Phosphate Substituted Quinolizine Derivative, and methods of using the Phosphate Substituted Quinolizine Derivatives for treating or preventing HIV infection in a subject.

Abstract: Mucus-penetrating liposomal nanoparticles and methods of making and using thereof are described herein. The nanoparticles contain one or more lipids, one or more PEG-conjugated lipids, and optionally one or more additional materials that physically and/or chemically stabilize the particles. The nanoparticle have an average diameter of about 100 nm to about 300 nm, preferably from about 100 nm to about 250 nm, more preferably from about 100 nm to about 200 nm. The particles are mobile in mucus. The liposomes can further contain one or more therapeutic, prophylactic, and/or diagnostic agent to be delivered to a mucosal surface, such as the CV tract, the colon, the nose, the lungs, and/or the eyes. The liposomes can further contain one or more CEST agents to allow real time imaging of the particles in a live animal. The particles may also further contain an imaging agent, such as a fluorescent label.

Abstract: The present invention is directed to compounds of generic formula I: or pharmaceutically acceptable salts thereof that are believed to be useful as an A2A-receptor antagonist.

Abstract: There are provided a driving method of a display panel and a driving module, a display panel and a display apparatus, which are capable of reducing power consumption of the display panel. The driving method of the display panel comprises: determining positions of gate lines to be scanned; determining offset current values according to the positions of the gate lines to be scanned; and generating driving signals of GOA units corresponding to the gate lines to be scanned according to the offset current values and clock signals of the display panel. The driving method of the display panel and the driving module, the display panel and the display apparatus determine the offset current values according to the positions of the gate lines to be scanned, and the amplitude of the offset current values only needs to ensure the normal display of the display panel when the gate lines to be scanned are scanned, thereby power consumption of the display panel is reduced.

Abstract: The present invention relates to Substituted Quinolizine Derivatives of Formula (I): and pharmaceutically acceptable salts or prodrug thereof, wherein X, Y, R1, R2, R3, R4, R5, R9 and R10 are as defined herein. The present invention also relates to compositions comprising at least one Substituted Quinolizine Derivative, and methods of using the Substituted Quinolizine Derivatives for treating or preventing HIV infection in a subject.

Abstract: A system and method for signal processing in a cable modem termination system (CMTS) is provided. A CMTS receiver in communication with a plurality of cable modems at a upstream signal or a cable modem receiver in communication with the CMTS at a downstream signal. A plurality of Advanced Time Division Multiple Access (“ATDMA”) channel processors include a filter for recovering an ATDMA signal and a Orthogonal Frequency Division Multiplexing (“OFDM”) channel processor includes a filter for processing a combined OFDM and ATDMA signal. A summation module subtracts the ATDMA signal from the combined ATDMA and OFDM signal to obtain a clean OFDM signal.

Abstract: The present invention relates to novel pyridino[1,2-?]pyrimidone compounds represented by formula (I) or pharmaceutically acceptable salts thereof; and a method of use thereof for treating tumors.

Abstract: The present invention relates to Substituted Quinolizine Derivatives of Formula (I): and pharmaceutically acceptable salts or prodrug thereof, wherein X, Y, R1, R2, R3, R4, R5, R9 and R10 are as defined herein. The present invention also relates to compositions comprising at least one Substituted Quinolizine Derivative, and methods of using the Substituted Quinolizine Derivatives for treating or preventing HIV infection in a subject.

Abstract: The present invention relates to novel pyridino[1,2-?]pyrimidone compounds represented by formula (I) or pharmaceutically acceptable salts thereof; and a method of use thereof for treating tumors, such as colon cancer and gastric cancer.

Abstract: The present disclosure discloses an information processing method, including the steps of acquiring at least one executable file of a specified type; extracting a first operation instruction from the at least one executable file of the specified type; determining the first operation instruction as a feature instruction if a preset policy is met; extracting a feature value of the feature instruction; constructing a virus classification model based on the feature value of the feature instruction for obtaining a virus structural feature parameter; extracting a second operation instruction from at least one to-be-analyzed file when the at least one to-be-analyzed file is identified according to the virus classification model; and identifying the to-be-analyzed file as a virus file if the feature value of the second operation instruction corresponds to the virus structural feature parameter.

Abstract: A system and method for signal processing in a cable modem termination system (CMTS) is provided. A CMTS receiver in communication with a plurality of cable modems at a upstream signal or a cable modem receiver in communication with the CMTS at a downstream signal. A plurality of ATDMA channel processors include a filter for recovering an ATDMA signal and a OFDM channel processor includes a filter for processing a combined OFDM and ATDMA signal. A summation module subtracts the ATDMA signal from the combined ATDMA and OFDM signal to obtain a clean OFDM signal.

Abstract: An electronic module includes a base, a carrying structure, an electronic component and a cable. The carrying structure includes a carrying portion and a cable arranging portion. The carrying portion is slidably disposed in the base, the cable arranging portion is connected to the carrying portion, and at least a part of the cable arranging portion is adapted to be bent. The electronic component is carried on the carrying portion. The cable is connected between the electronic component and the base and is position-limited by the cable arranging portion. When the carrying portion at least partially slides out of the base, the cable is deformed with the cable arranging portion. In addition, an electronic apparatus having the electronic module is also provided.

Abstract: A system (100) and method for generating machining control data of a numerical control machine tool. The system (100) comprises a server (10) and at least one terminal device (30). The server (10) is installed with computer-aided manufacturing software, a numerical control machine tool model library and a cutter and fixture library. The terminal device (30) is connected to the server (10) through the Internet (20) to generate machining program data of a part model and/or to carry out machining simulation of a part model. The method for generating machining control data of a numerical control machine tool comprises: sending a part model file to the server (10) through the Internet (20); and generating program code that can be executed by the numerical control machine tool. The system (100) and the method have the beneficial technical effects of being convenient to operate, low in cost and flexible and easy to use and so on.